Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,227,215 papers from all fields of science
Search
Sign In
Create Free Account
retapamulin
Known as:
retapamulin [Chemical/Ingredient]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Anti-Bacterial Agents
Bacterial Infections
pleuromutilin
Broader (1)
Bridged Bicyclo Compounds, Heterocyclic
Narrower (1)
SB 275833
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
What is the best treatment for impetigo
J. Shim
,
M. Qui
2014
Corpus ID: 69126103
A Although evidence is lacking to support a single best treatment for impetigo, topical mupirocin, fusidic acid, gentamicin, and…
Expand
2013
2013
The Safety and Efficacy of Topical Retapamulin Ointment Versus Placebo Ointment in the Treatment of Secondarily Infected Traumatic Lesions: A Randomized, Double-blind Superiority Study
J. Tomayko
,
Gang Li
,
J. Breton
,
Nicole E Scangarella-Oman
,
M. Dalessandro
,
Michael Martin
Advances in Skin & Wound Care
2013
Corpus ID: 20699278
OBJECTIVE: To evaluate whether retapamulin 1% is clinically superior to a placebo in the treatment of patients with secondarily…
Expand
Review
2008
Review
2008
Retapamulin (Altargo): novel antibacterial for impetigo
S. Chaplin
,
Cameron T. C. Kennedy
2008
Corpus ID: 72673635
Retapamulin is a new topical antibacterial licensed for impetigo and minor skin infections. In our New products review Steve…
Expand
Review
2008
Review
2008
Fusidic acid in skin and soft-tissue infections
B.-H. Long
2008
Corpus ID: 49291813
Fusidic acid Fusidanes Inhibits protein synthesis Mupirocin Unique Inhibits protein synthesis Neomycin Aminoglycoside Inhibits…
Expand
2007
2007
Retapamulin (Altabax) 1% Topical ointment for the Treatment of Impetigo
B. Coutinho
2007
Corpus ID: 80249152
Retapamulin is an effective alternative to topical mupirocin in the treatment of limited-area impetigo in patients older than…
Expand
2007
2007
FDA Approves Topical Retapamulin for Impetigo
Michael Smith
2007
Corpus ID: 149911526
ROCKVILLE, Md. -- The FDA has given a thumbs up to a topical antibiotic treatment for impetigo in children who are nine months or…
Expand
2006
2006
Retapamulin. Pleuromutilin antibiotic
B. Boyd
,
J. Castaǹer
2006
Corpus ID: 78617065
Due to the emergence of rnultidrug-resistant microorganisms, research efforts are focusing on new classes of antibacterials with…
Expand
2005
2005
In Vitro Activity of Retapamulin (SB-275833), a Novel Topical Antimicrobial, against 3721 Gram-Positive Isolates Associated with Skin and Skin Structure Infections (SSSIs) From 17 Sites in North…
B. Johnson
,
A. Jordan
,
+5 authors
R. Badal
2005
Corpus ID: 85983331
®, Cleveland, OH, USA) was used for all Staphylococcus species. Fresh lysed horse blood (Hemostat Laboratories, Dixon, CA, USA…
Expand
2005
2005
Retapamulin (SB-275833), a Novel Pleuromutilin - a Multi-center Global Surveillance of Activity Against 3,797 Beta and Alpha Hemolytic Streptococci Isolated from Skin and Skin Structure Infections…
S. Bouchillon
,
D. Hoban
,
+4 authors
J. Johnson
2005
Corpus ID: 85942924
Background: Retapamulin is a novel pleuromutilin currently in development as a topical antimicrobial agent for the treatment of…
Expand
2005
2005
Retapamulin (SB-275833), A Novel Topical Pleuromutilin, Is Active Against Community Associated Methicillin- and Mupirocin-Resistant S. aureus Isolates From Uncomplicated Skin And Skin Structure…
S. Bouchillon
,
B. Johnson
,
+5 authors
R. Badal
2005
Corpus ID: 86344218
Standards [NCCLS]) guidelines. Results: Methicillin resistance (MRSA) was detected in 649/1975 (32.9%) of S. aureus isolates…
Expand